Fermented Brown Rice and Rice Bran with Aspergillus Oryzae as A New Promising Agent for Cancer Prevention | Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.6, No. 3)Publication Date: 2019-11-19
Authors : Hideki Mori;
Page : 232-233
Keywords : Open Access Journals of Biomedicine; Journal of Biomedicine; Biomedicine Journal of Health Science;
Abstract
Fermented brown rice and rice bran with Aspergillus (A) oryzae (FBRA) is a food manufactured by fermenting a mixture of brown rice and rice bran with A. oryzae. The fermentation is proved to increase antioxidant phytochemicals. FBRA prevented carcinogeninduced carcinogenesis in 7 animal models. FBRA also acted against spontaneous development of neoplasms in 3 animal models. FBRA is suggested to be a new promising agent for prevention of human cancers. It has been recognized that dietary factors play an important role in prevention of occurrence of human cancers. Epidemiological studies have shown that high intake of fruits, vegetables and cereal foods decrease the risk for the occurrence of cancers in different organs. Rice is one of the major cereals, and is the most consumed food worldwide, particularly in Asian countries. Rice seeds and rice bran contain fibers and various types of antioxidants including phenolic acids, phytic acid and tocopherols. Cellular and preclinical studies have supported that micronutrients in rice bran have effects against the occurrence of several types of cancers. Our group has done a large-scale study to determine possible agents to suppress occurring cancers using animal models and found a number of natural or synthetic substances including rice-germ.
Other Latest Articles
- Lychee Honey Accelerates Antibacterial Efficacy of Penicillin and Amoxiclav Against Gram-Positive Bacteria in Libya | Biomedgrid
- Major, Minor and Trace Elements Linum Usitatissimum in Libya | Biomedgrid
- Evaluation of Antifungal Activity of Nine Members of Family Euphorbiaceae of Lahore Region against Aspergillus niger, Rhizopus oryzae & Alternaria solani | Biomedgrid
- Developments in CRM197 Glycoconjugates for Anticancer Vaccines | Biomedgrid
- Experimental Cancer Models | Biomedgrid
Last modified: 2022-02-26 15:25:40